bluebird bio Inc (NASDAQ:BLUE)
Q3 2017 Earnings Conference Call
November 1, 2017 8:30 AM ET
Executives
Liz Pingpank – Associate Director, Corporate Communications
Nick Leschly – Chief Executive Officer
Mohammed Asmal – Vice President, Clinical Development
Philip Gregory – Chief Scientific Officer
Analysts
Salveen Richter – Goldman Sachs
Schimmer – Evercore ISI
Eric Schmidt – Cowen & Company
Cory Kasimov – JP Morgan
Jim Birchenough – Wells Fargo
Matthew Harrison – Morgan Stanley
Dane Leone – BTIG
Michael Schmidt – Leerink Partners
David Nierengarten – Wedbush Securities
Matthew Luchini – BMO Capital
Ying Huang – Bank of America
Vincent Chen – Bernstein
Biren Amin – Jefferies
Huidong Wang – Barclays
Operator
Good day, ladies and gentlemen, and welcome to the bluebird quarterly update and ASH 2017 Abstract Call.
[Operator Instructions] I’d now like to introduce your host for today’s conference, Ms. Liz Pingpank. Ma’am, you may begin.
